Skip to main content

Lung Tumor clinical trials at UC Health
3 in progress, 2 open to eligible people

  • COM701 in Subjects With Advanced Solid Tumors

    open to eligible people ages 18 years and up

    This is a Phase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary clinical activity of COM701 as monotherapy and in combination with a programmed cell death protein 1 (PD-1) inhibitor.

    at UCLA

  • Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers

    open to eligible people ages 1 month and up

    This is a Phase 1/2, multi-center, open-label study designed to evaluate the safety and efficacy of LOXO-195 when administered orally to patients age ≥ 1 month and older with NTRK fusion cancers treated with a prior TRK inhibitor.

    at UCLA UCSD

  • The Watch the Spot Trial

    “Compare two”

    Sorry, accepting new patients by invitation only

    This study will compare two clinically accepted protocols for surveillance imaging in individuals who are found to have a small pulmonary nodule on chest computed tomography (CT) scans.

    at UC Davis UCSF

Last updated: